Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes

Experimental and Therapeutic Medicine

Volumn 5, Issue 2, 2013, Pages 572-580

  Panek, Michał ^a   Pietras, Tadeusz ^a   Fabijan, Artur ^a   Miłanowski, Maciej ^a   Wieteska, Łukasz ^a   Górski, Paweł ^a   Kuna, Piotr ^a   Szemraj, Janusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Asthma; Glucocorticoid receptor; Glucocorticoid receptor gene polymorphisms; Inflammation; NR3C1 gene; Restriction fragment length polymorphism; Single nucleotide polymorphism

Indexed keywords

GLUCOCORTICOID RECEPTOR; NUCLEAR RECEPTOR NR3C1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84871354280     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.809     Document Type: Article

References (50)

1. Global Initiative for Asthma 2007: GINA executive summary. Eur Respir J 31: 143-178, 2008.
2. National Institutes of Health: Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program (NAEPP) Expert Panel Report 3. Summary Report 2007. NIH Publication Number 08-5846. National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, MD, 2007.
3. Wenzel S: Asthma: defining of the persistent adult phenotypes. Lancet 368: 804-813, 2006.
4. Droszcz W (ed): Astma. Wydawnictwo Lekarskie PZWL, Warsaw, 2007 (In Polish).
5. Kino T, De Martino M, Charmandari E, etal: Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol 85: 457-467, 2003.
6. Derijk R and de Kloet E: Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol583: 303-311, 2008.
7. Bamberger C, Bamberger A, de Castro M, etal: G. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95: 2435-2441, 1995.
8. Ito K, Chung K and Adcock I: Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117: 522-543, 2006.
9. DeRijk R, Schaaf M and de Kloet E: Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 81: 103-122, 2002.
10. Grzanka A and Rogala B: Molecular mechanism of glucocorticoids and difficult asthma. Allerg Asthma Immunol 5: 247-252, 2000.
11. Panek M, Pietras T, Antczak A, etal: The N363S and I559N single nucleotide polymorphisms of the h-GR/NR3C1 gene in patients with bronchial asthma. Int J Mol Med 30: 142-150, 2012;
12. Adcock IM, Ford P, etal: Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 8: 171-178, 2008.
13. Barnes P: Molecular mechanisms of glucocorticoid action in asthma. Pulm Pharmacol Ther 10: 3-19, 1997.
14. Panek M, Pietras T, Kupryś-Lipińska I, etal: The analysis of the factors influencing the development of glucocorticoid resistance in the etiopathogenesis of severe bronchial asthma. Postepy Biochem 56: 373-382, 2010 (In Polish).
15. Leung D and Bloom J: Update on glucocorticoid action and resistance. J Allergy Clin Immunol 111: 3-22, 2003.
16. Russcher H, Dalm V, de Jong F, etal: Associations between promoter usage and alternative splicing of the glucocorticoid receptor gene. J Mol Endocrinol 38: 91-98, 2007.
17. Van der Velden V: Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm 7: 229-237, 1998.
18. Beato M, Chalepakis G, Schauer M, etal: DNA regulatory elements for steroid hormones. J Steroid Biochem Mol Biol 32: 737-747, 1989.
19. Thomas M and Chiang C: The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol 41: 105-117, 2006.
20. Smale S and Kadonaga J: The RNA polymerase II core promoter. Annu Rev Biochem 72: 449-479, 2003.
21. Wu S and Chiang C: TATA-binding protein-associated factors enhance the recruitment of RNA polymerase II by transcriptional activators. J Biol Chem 276: 34235-34243, 2001.
22. Bulas M, Trelińska J, Stolarska M, etal: Association of steroid receptor gene (NR3C1) polymorphism with clinical course of lymphoproliferative disorders in children-preliminary results. Onkol Pol 2: 77-81, 2008 (In Polish).
23. Bulas M, Pierlejewski F and Młynarski W: Glucocorticosteroid resistance in lymphoproliferative diseases in children. Przegla{ogonek}d Pediatryczny 1: 57-61, 2009 (In Polish).
24. Van Rossum E and Lamberts S: Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 59: 333-357, 2004.
25. Nicolaides N, Galata Z, Kino T, etal: The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75: 1-12, 2010.
26. Bray P and Cotton R: Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat 2003 21: 557-568.
27. Mwinyi J, Wenger C, Eloranta J and Kullak-Ublick G: Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. World J Gastroenterol 16: 3888-3896, 2010.
28. Van Rossum E, Koper J, van den Beld A, etal: Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrinol 59: 585-592, 2003.
29. Buemann B, Vohl M, Chagnon M, etal: Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 5: 186-192, 1997.
30. Panarelli M, Holloway C, Fraser R, etal: Glucocorticoid receptor polymorphism, skin vasoconstriction and other metabolic intermediate phenotypes in normal subjects. J Clin Endo Met 83: 1846-1852, 1998.
31. De Iudicibus S, Franca R, Martelossi S, etal: Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 17: 1095-1108, 2011.
32. De Lange P, Koper J, Huizenga N, etal: Differential hormone-dependent transcriptional activation and repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol 11: 1156-1164, 1997.
33. Miller M, Hankinson J, Brusasco V, etal: Standardisation of Spirometry. Eur Respir J 26: 319-338, 2005.
34. Nathan R, Sorkness C, Kosinski M, etal: T. Development of the test: a survey for assessing asthma control. J Allergy Clin Immunol 113: 59-65, 2004.
35. Dreborg S, Backman A and Bosomba A: Skin tests used in type I allergy testing. Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 44: 1-59, 1989.
36. Wittwer CT: High-resolution DNA melting analysis: advancements and limitations. Hum Mutat 30: 857-859, 2009.
37. Vossen RH, Aten E, Roos A, etal: High-resolution melting analysis (HRMA)-more than just sequence variant screening. Hum Mutat 30: 860-866, 2009.
38. Tindall EA, Petersen DC, Woodbridge P, etal: Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments. Hum Mutat 30: 876-883, 2009.
39. Lyon E and Wittwer CT: LightCycler technology in molecular diagnostics. J Mol Diagn 11: 93-101, 2009.
40. Dobrowolski SF, Gray J, Miller T, etal: Identifying sequence variants in the human mitochondrial genome using high-resolution melt (HRM) profiling. Hum Mutat 30: 891-898, 2009.
41. Szabó V, Borgulya G, Filkorn T, etal: The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy. Mol Vis 13: 659-666, 2007.
42. Institute of Human Genetics: Case-control studies. Tests for deviation from Hardy-Weinberg equilibrium and tests for association. http://ihg.gsf.de
43. Sasieni PD: From genotypes to genes: doubling the sample size. Biometrics 53: 1253-1261, 1997.
44. Weir BS: Statistical Data Analysis II. Methods for Discrete Population Genetic Data. 2nd edition. Sinauer Associates., Inc., Sunderland, MA, USA, pp 91-140, 1996.
45. R Development Core Team: R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, 2011, http://www.R-project.org.
46. Andreasen N and Olsen S: Negative vs. positive schizophrenia: definition and validation. Arch Gen Psychiatry 39: 789-794, 1982.
47. Pietras T, Panek M, Tworek D, etal: The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot study. Mol Biol Rep 38: 3953-3958, 2011.
48. Panek M, Pietras T, Antczak A, et al: The role of functional single nucleotide polymorphisms of the human glucocorticoid receptor gene NR3C1 in Polish patients with bronchial asthma. Mol Biol Rep 39: 4749-4757, 2012.
49. Panek M, Pietras T and Kuna P. Contemporary management of COPD in the view of the new GOLD guidelines. Terapia 271: 71-77, 2012.
50. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from URL: http:// http://www.goldcopd.org.